FGEN Delivers 12th Consecutive Dividend Increase and Resilient NAV Total Return of 6.2%

Why FGEN delivered a positive 6.2% NAV total return despite NAV per share slipping

This is the part that can confuse newer investors. NAV, or net asset value, is the estimated value of the trust’s assets minus liabilities. FGEN’s NAV per share fell from 106.5p to 105.2p, yet NAV total return was positive at 6.2% because shareholders also received dividends during the year.

In other words, the assets did not grow fast enough to fully offset the 7.9p paid out in dividends, but the total return picture was still positive once that income was included. That is respectable, especially in a difficult year for listed renewables and infrastructure.

The main drags on NAV were lower power price forecasts, which knocked 2.0p off NAV per share, and only a partial offset from inflation, which added 1.1p. Share buy-backs helped by 0.7p, and other movements added 6.8p.

That tells you something useful: FGEN is still getting real value from portfolio management and discount rate unwind, but power price assumptions remain a real swing factor.

Environmental infrastructure portfolio cash flow remains resilient but not flawless

The portfolio now holds 39 assets across renewable generation, other energy infrastructure and sustainable resource management. That spread matters because it reduces reliance on one revenue source, one technology or one weather pattern.

Operationally, the picture was decent. Renewable energy generation rose to 1,338 GWh from 1,272 GWh, while greenhouse gas emissions avoided increased to 223,140 tCO2e from 193,663 tCO2e.

There were also some bright operational spots. CNG Fuels increased fuel dispensed by 19%, the Glasshouse expanded sales and is now supplying eight of the 10 largest UK clinics, and Rjukan started producing and harvesting trout. These three growth assets represent about 18% of the portfolio, and they are central to management’s pitch that FGEN can grow organically without raising fresh equity.

That said, not everything went smoothly. Cramlington biomass had downtime and extra capital spending requirements, while hydro output was badly hit by dry conditions. Rjukan is progressing, but it still needs upgrades and ongoing shareholder support during ramp-up.

My view is that the diversified structure is doing its job, but investors should not kid themselves that this is a low-effort portfolio. There are moving parts here, and some of the more specialist assets carry execution risk.

Power prices and regulatory changes hit FGEN valuation in 2026

The biggest valuation headache came from assumptions, not disasters. Forecast power prices reduced the portfolio value by £12.2 million.

Two policy changes mattered. First, the UK government’s decision to move Renewables Obligation and Feed-in Tariff indexation from RPI to CPI cut NAV by £3.1 million, or 0.5p per share. Second, the removal of Carbon Price Support from April 2028 reduced NAV by £2.3 million, or 0.4p per share.

This is a reminder that infrastructure trusts are not just about wind turbines and solar panels. They are also about regulation, subsidy structures and long-term pricing assumptions. When those move, valuations move too.

One strong counterpoint was biomethane. FGEN recognised an £8.7 million uplift, equivalent to 1.4p per share, from extending the lives of seven anaerobic digestion assets beyond subsidy expiry. That is a genuinely encouraging sign because it suggests parts of the portfolio may have been valued too conservatively before.

FGEN balance sheet, buy-backs and the persistent share price discount

The balance sheet remains sensible. Gearing – effectively borrowing as a share of gross asset value – was 28.8%, basically flat year on year and still conservative by sector standards.

FGEN had £123.1 million drawn on its revolving credit facility at year end, later extended by one year with an extra £15 million accordion facility activated. That gives it funding flexibility, but investors should still watch debt costs and refinancing conditions closely if interest rates stay higher for longer.

The trust also bought back £10.8 million of shares during the year, following the earlier £30 million buy-back programme completed in September 2025. Buy-backs helped NAV per share, but they have not fixed the market rating problem. With the shares at 68.0p versus NAV per share of 105.2p, the market is still applying a heavy discount.

That is the real frustration. The portfolio is delivering income and a positive NAV total return, but the stock market still does not fully believe the sector’s valuations.

Board changes and the big things FGEN shareholders should watch next

There is also a governance change worth noting. Ed Warner will step down as Chair at the AGM on 17 September 2026, with Stephanie Coxon taking over. That looks like an orderly handover rather than a red flag.

Going forward, the big watch points are clear:

• whether cash generation stays strong enough to keep dividend cover within the 1.20x to 1.30x target range;
• whether growth assets like CNG Fuels, Rjukan and the Glasshouse can ramp up without nasty surprises;
• whether lower power prices or fresh policy tweaks create more NAV pressure; and
• whether the discount to NAV narrows at all.

What FGEN annual results mean for retail investors

On balance, this is a good update. Not a barnstormer, but good. FGEN is doing the hard bits right – paying and growing the dividend, keeping gearing under control, and getting enough cash out of the portfolio to support the income story.

The weaker side is that NAV per share still slipped, cash receipts were lower year on year, and the market continues to mark the shares well below asset value. So the income case looks stronger than the capital growth case today.

If you own FGEN for yield and can tolerate valuation noise, this result should be reassuring. If you are hoping for a quick rerating, you may need more patience.